X-Received: by 2002:a05:620a:46a4:b0:6fa:11f6:518f with SMTP id bq36-20020a05620a46a400b006fa11f6518fmr425419qkb.774.1671837468975;
Fri, 23 Dec 2022 15:17:48 -0800 (PST)
X-Received: by 2002:ad4:4087:0:b0:4c7:2ebb:6eb1 with SMTP id
l7-20020ad44087000000b004c72ebb6eb1mr525537qvp.88.1671837468764; Fri, 23 Dec
2022 15:17:48 -0800 (PST)
Path: i2pn2.org!i2pn.org!usenet.blueworldhosting.com!feed1.usenet.blueworldhosting.com!peer02.iad!feed-me.highwinds-media.com!news.highwinds-media.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: alt.comp.hardware.pc-homebuilt
Date: Fri, 23 Dec 2022 15:17:48 -0800 (PST)
Injection-Info: google-groups.googlegroups.com; posting-host=91.219.212.89; posting-account=lHEcUQkAAACsts7kGzmcJY3S9lf6KbSh
NNTP-Posting-Host: 91.219.212.89
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <92b65eeb-7f8b-46d1-84ea-8c071fb76ff7n@googlegroups.com>
Subject: (PDF) Antibiotic Drug Discovery - New Targets and Molecular Entities
by Firestine
From: kifawaha@gmail.com (Kifa Waha)
Injection-Date: Fri, 23 Dec 2022 23:17:48 +0000
Content-Type: text/plain; charset="UTF-8"
X-Received-Bytes: 1293